Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice

JOURNAL ARTICLE published April 2020 in Gastroenterology

Research funded by University of Kansas Cancer Center (P30CA168524) | National Institutes of Health (R01CA182872,R01CA190291) | National Institutes of Health (NCRR P20 RR016443,P30CA168524)

Authors: Prasad Dandawate | Gaurav Kaushik | Chandrayee Ghosh | David Standing | Afreen Asif Ali Sayed | Sonali Choudhury | Dharmalingam Subramaniam | Ann Manzardo | Tuhina Banerjee | Santimukul Santra | Prabhu Ramamoorthy | Merlin Butler | Subhash B. Padhye | Joaquina Baranda | Anup Kasi | Weijing Sun | Ossama Tawfik | Domenico Coppola | Mokenge Malafa | Shahid Umar | Michael J. Soares | Subhrajit Saha | Scott J. Weir | Animesh Dhar | Roy A. Jensen | Sufi Mary Thomas | Shrikant Anant